MXPA02000801A - Homologo humano de polinucleotidos, nesp55 de proteina secretora de neuroendocrino bovino y usos el mismo relacionado con la obesidad. - Google Patents

Homologo humano de polinucleotidos, nesp55 de proteina secretora de neuroendocrino bovino y usos el mismo relacionado con la obesidad.

Info

Publication number
MXPA02000801A
MXPA02000801A MXPA02000801A MXPA02000801A MXPA02000801A MX PA02000801 A MXPA02000801 A MX PA02000801A MX PA02000801 A MXPA02000801 A MX PA02000801A MX PA02000801 A MXPA02000801 A MX PA02000801A MX PA02000801 A MXPA02000801 A MX PA02000801A
Authority
MX
Mexico
Prior art keywords
nesp55
obesity
polynucleotides
bovine
linked
Prior art date
Application number
MXPA02000801A
Other languages
English (en)
Inventor
Clark Fraser Douglas
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of MXPA02000801A publication Critical patent/MXPA02000801A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un polipeptido que se puede derivar de NESP55 humano, en donde el polipeptido se puede derivar o anticipar de la secuencia de aminoacido de NESP55 humano que sera derivable mediante la disociacion edoproteolitica de un polipeptido que tiene la secuencia de aminoacido (I) o (II) (NESP55 humano) o una variante de la misma, en donde la variante de polipeptido tiene una secuencia de aminoacido que tiene al menos 90% de identidad con la secuencia de aminoacido proporcionada sola. La NESP55 o fragmentos de la misma, pueden ser utiles en medicina para el tratamiento de la obesidad.
MXPA02000801A 1999-07-22 2000-07-20 Homologo humano de polinucleotidos, nesp55 de proteina secretora de neuroendocrino bovino y usos el mismo relacionado con la obesidad. MXPA02000801A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9917165.4A GB9917165D0 (en) 1999-07-22 1999-07-22 Polypeptides polynuclcotides and uses thereof
PCT/EP2000/006921 WO2001007617A1 (en) 1999-07-22 2000-07-20 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity

Publications (1)

Publication Number Publication Date
MXPA02000801A true MXPA02000801A (es) 2004-03-19

Family

ID=10857699

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02000801A MXPA02000801A (es) 1999-07-22 2000-07-20 Homologo humano de polinucleotidos, nesp55 de proteina secretora de neuroendocrino bovino y usos el mismo relacionado con la obesidad.

Country Status (7)

Country Link
EP (1) EP1200591A1 (es)
JP (1) JP2003505084A (es)
AU (1) AU5986000A (es)
CA (1) CA2380942A1 (es)
GB (1) GB9917165D0 (es)
MX (1) MXPA02000801A (es)
WO (1) WO2001007617A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003006688A2 (en) * 2001-07-13 2003-01-23 University Of Aarhus Methods for diagnosis and treatment of diseases associated with altered expression of gnas
WO2003027320A2 (en) * 2001-09-24 2003-04-03 University Of Aarhus Methods for diagnosis and treatment of diseases associated with altered expression of pik3r1
WO2010010383A1 (en) * 2008-07-21 2010-01-28 Isis Innovation Limited Treatment of obesity
CA2845617A1 (en) * 2011-08-18 2013-02-21 Otago Innovation Limited Cardiovascular therapeutics
US11205153B1 (en) 2013-11-15 2021-12-21 Grubhub Holdings, Inc. System and method for determining time of delivery of order

Also Published As

Publication number Publication date
EP1200591A1 (en) 2002-05-02
CA2380942A1 (en) 2002-02-01
JP2003505084A (ja) 2003-02-12
WO2001007617A1 (en) 2001-02-01
AU5986000A (en) 2001-02-13
GB9917165D0 (en) 1999-09-22

Similar Documents

Publication Publication Date Title
WO2001006988A3 (en) Super-active porcine growth hormone releasing hormone analog
PL340755A1 (en) Polypeptide-10 similar to mammal cytokin
HU902697D0 (en) Process for the enzymatic removal of the n-terminal sequence of proteins
DE60135393D1 (de) Allelische Variante des Interferon-ähnlichen Proteins Zcyto21
CA2287521A1 (en) Human recombinant beta-interferon with improved solubility
WO2000075173A3 (en) Peptide fragments of colostrinin
WO1999024058A3 (en) Neuronal uses of bmp-11
MXPA02000801A (es) Homologo humano de polinucleotidos, nesp55 de proteina secretora de neuroendocrino bovino y usos el mismo relacionado con la obesidad.
GB9801408D0 (en) Frozen food product
EP0249477A3 (en) Functional recombinant analog polypeptides devoid of hydrophobic amino acids
WO2004005317A3 (en) Thrombin peptide derivative dimers
DE60036555D1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
ES8605296A1 (es) Procedimiento de producir factor viii-r humano
WO1998022580A3 (en) Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
WO2001098355A3 (en) Cgi-69 compositions and methods of use
EP0723016A3 (en) Leukocyte activation factor
DE69623803D1 (de) Verwendung von KASEINFRAGMENTEn als WACHSTUMERFÖRDERer
EP0750040A3 (en) Macrophage stimulating protein variant and method for producing the same
EP0287997A3 (en) Des-19-leucine, 20-glutamine, 21-threonine-calcitonin
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
BR0012740A (pt) Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego
EP0290029A3 (en) (19-alanine) calcitonin
WO2002096355A3 (en) Compositions and methods for adipose abundant protein
WO2002097036A3 (en) Compositions and methods for adipose abundant protein